{"id":"NCT01106677","sponsor":"Janssen Research & Development, LLC","briefTitle":"The CANTATA-D Trial (CANagliflozin Treatment and Trial Analysis - DPP-4 Inhibitor Comparator Trial)","officialTitle":"A Randomized, Double-Blind, Placebo and Active-Controlled, 4-Arm, Parallel Group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-05","primaryCompletion":"2011-10","completion":"2012-05","firstPosted":"2010-04-20","resultsPosted":"2013-07-30","lastUpdate":"2013-07-30"},"enrollment":1284,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Canagliflozin","otherNames":[]},{"type":"DRUG","name":"Sitagliptin","otherNames":[]},{"type":"DRUG","name":"Metformin immediate release","otherNames":[]}],"arms":[{"label":"Canagliflozin 100 mg","type":"EXPERIMENTAL"},{"label":"Canagliflozin 300 mg","type":"EXPERIMENTAL"},{"label":"Sitagliptin 100 mg","type":"ACTIVE_COMPARATOR"},{"label":"Placebo/Sitagliptin","type":"OTHER"}],"summary":"The purpose of this study is to evaluate the efficacy and safety of canagliflozin compared with sitagliptin and placebo in patients with type 2 diabetes mellitus who are receiving treatment with metformin monotherapy (i.e., treatment with a single drug) and have inadequate glycemic (blood sugar) control.","primaryOutcome":{"measure":"Change in HbA1c From Baseline to Week 26","timeFrame":"Day 1 (Baseline) and Week 26","effectByArm":[{"arm":"Placebo/Sitagliptin","deltaMin":-0.17,"sd":0.06},{"arm":"Canagliflozin 100 mg","deltaMin":-0.79,"sd":0.044},{"arm":"Canagliflozin 300 mg","deltaMin":-0.94,"sd":0.044},{"arm":"Sitagliptin 100 mg","deltaMin":-0.82,"sd":0.044}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"},{"comp":"OG000 vs OG002","p":"<0.001"},{"comp":"OG000 vs OG003","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":1},"locations":{"siteCount":125,"countries":["United States","Argentina","Bulgaria","Colombia","Czechia","Estonia","Greece","India","Latvia","Malaysia","Mexico","Peru","Poland","Portugal","Puerto Rico","Russia","Singapore","Slovakia","Sweden","Thailand","Turkey (TÃ¼rkiye)","Ukraine"]},"refs":{"pmids":["29313267","28327140","28241822","28197834","27977934","27600862","27391951","26580237","26579834","26373629","26121561","25813214","25795432","25329038","24918789","24786834","24742013","24517339","24026211"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":183},"commonTop":["Diarrhoea","Urinary tract infection","Nasopharyngitis","Headache","Upper respiratory tract infection"]}}